Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Operating Expenses | 2,556 | 3,609 | 2,797 | 3,589 | 3,880 |
| Operating Income | -2,556 | -3,609 | -2,797 | -3,589 | -3,880 |
| Other Income | 202 | 80 | 22 | 1 | 1 |
| Pre-tax Income | -2,354 | -3,529 | -2,775 | -3,588 | -3,879 |
| Net Income Continuous | -2,354 | -3,529 | -2,775 | -3,588 | -3,879 |
| Minority Interests | -32 | -53 | -29 | -44 | -50 |
| Net Income | $-2,322 | $-3,476 | $-2,746 | $-3,544 | $-3,829 |
| EPS Basic Total Ops | -0.08 | -0.11 | -0.09 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.08 | -0.11 | -0.09 | -0.12 | -0.13 |
| EPS Diluted Total Ops | -0.08 | -0.11 | -0.09 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.08 | -0.11 | -0.09 | -0.12 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.12 | -0.09 | N/A | N/A |
| EBITDA(a) | $-2,545 | $-3,598 | $-2,787 | $-3,578 | $-3,870 |